These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3680587)

  • 1. Effect of two different meals on bioavailability of nilvadipine in healthy volunteers.
    Terakawa M; Tokuma Y; Shishido A; Yasuda K; Noguchi H
    J Clin Pharmacol; 1987 Apr; 27(4):293-6. PubMed ID: 3680587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of nilvadipine in healthy volunteers.
    Terakawa M; Tokuma Y; Shishido A; Noguchi H
    J Clin Pharmacol; 1987 Feb; 27(2):111-7. PubMed ID: 3680562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of (+)- and (-)-nilvadipine after oral dosing with racemic (+)-nilvadipine in man.
    Tokuma Y; Fujiwara T; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):229-37. PubMed ID: 3659571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.
    Wonnemann M; Schug B; Schmücker K; Brendel E; van Zwieten PA; Blume H
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):38-48. PubMed ID: 16425970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of nilvadipine.
    von Nieciecki A; Huber HJ; Stanislaus F
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S22-9. PubMed ID: 1283185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption of amlodipine unaffected by food. Solid dose equivalent to solution dose.
    Faulkner JK; Hayden ML; Chasseaud LF; Taylor T
    Arzneimittelforschung; 1989 Jul; 39(7):799-801. PubMed ID: 2528959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple-dose pharmacokinetics of nilvadipine in healthy volunteers.
    Terakawa M; Tokuma Y; Kuwahara N; Shishido A; Noguchi H
    J Clin Pharmacol; 1988 Apr; 28(4):350-5. PubMed ID: 3392233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
    Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of orlistat on the bioavailability of a single dose of nifedipine extended-release tablets (Procardia XL) in healthy volunteers.
    Melia AT; Mulligan TE; Zhi J
    J Clin Pharmacol; 1996 Apr; 36(4):352-5. PubMed ID: 8728349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of two types of meal on the pharmacokinetics of a modified-release formulation of nifedipine (Adalat Retard).
    Armstrong J; Challenor VF; Macklin BS; Renwick AG; Waller DG
    Eur J Clin Pharmacol; 1997; 53(2):141-3. PubMed ID: 9403286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of rifampicin on the pharmacokinetics and pharmacodynamics of orally administered nilvadipine to healthy subjects.
    Saima S; Furuie K; Yoshimoto H; Fukuda J; Hayashi T; Echizen H
    Br J Clin Pharmacol; 2002 Feb; 53(2):203-6. PubMed ID: 11851646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of oral dosing rate on the hemodynamic and pharmacokinetic profile on nilvadipine.
    Cheung WK; Sia LL; Woodward DL; Graveline JF; Desjardins RE; Yacobi A; Silber BM
    J Clin Pharmacol; 1988 Nov; 28(11):1001-7. PubMed ID: 3243913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food interaction pharmacokinetic study of cordaflex 20 mg retard filmtablet in healthy volunteers.
    Balogh Nemes K; Horváth V; Grézal G; Horvai G; Hrabéczy-Páll A; Kocsi E; Drabant S; Csörgö M; Renczes G; Klebovich I
    Int J Clin Pharmacol Ther; 1998 May; 36(5):263-9. PubMed ID: 9629990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative bioavailability study of two nifedipine tablet formulations in healthy male volunteers.
    Niopas I; Daftsios AC; Xanthakis I; Nikolaidis N
    Int J Clin Pharmacol Ther; 2000 Jun; 38(6):309-14. PubMed ID: 10890580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of nilvadipine, a new dihydropyridine calcium antagonist, in mice, rats, rabbits and dogs.
    Tokuma Y; Sekiguchi M; Niwa T; Noguchi H
    Xenobiotica; 1988 Jan; 18(1):21-8. PubMed ID: 3354229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated plasma nilvadipine concentration after single and chronic oral administration to patients with chronic liver disease.
    Takata Y; Yoshizumi T; Ito Y; Kikuchi M; Ueno M; Tsukashima A; Kobayashi K; Fujishima M
    Eur J Clin Pharmacol; 1992; 42(5):475-9. PubMed ID: 1606993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
    Tokuma Y; Fujiwara T; Noguchi H
    Xenobiotica; 1987 Nov; 17(11):1341-9. PubMed ID: 3433803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and dynamic interactions of the angiotensin-converting enzyme inhibitor imidapril with hydrochlorothiazide, bisoprolol and nilvadipine.
    Breithaupt-Grögler K; Ungethüm W; Meurer-Witt B; Belz GG
    Eur J Clin Pharmacol; 2001 Jul; 57(4):275-84. PubMed ID: 11549204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.